Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
false falseProducts may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.
GSP Neonatal 17α-OH-progesterone assay
The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.
Assay Technology | DELFIA |
---|---|
Calibration Standards | Yes |
Detection Method | DELFIA |
Disorders | Congenital Adrenal Hyperplasia (CAH) |
Product Brand Name | GSP® |
Sample Type | Dried blood spots |